ArticleJournal of experimental & clinical cancer research : CR2023

Kremen2 drives the progression of non-small cell lung cancer by preventing SOCS3-mediated degradation of EGFR.

Yuxiao Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.